Vicarious Surgical, Inc. · OTC:RBOT
Vicarious Surgical — Investor Presentation (September 2025)
24 slides from Vicarious Surgical's investor presentation, Sep 23, 2025
Slide 1: Transforming Surgery: Open-like Access, Minimally Invasive
Transforming Surgery: Open - like Access, Minimally Invasive
Slide 2: Forward-looking statements
Vicarious Surgical This presentation includes “forward - looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. Vicarious Surgical’s actual results may differ from its expectations, estimates, and projections and,
Slide 3: Redefining Access, Expanding Markets & Advancing to Commercialization
Vicarious Surgical Redefining Access, Expanding Markets & Advancing to Commercialization “Large market, protected technology, and clear path to launch.” Open - like Access, Minimally Invasive: Single - port, 18 mm trocar, open - surgery reach & dexterity. Large Untapped Market: >5.6M U.S. abdominal
Slide 4: Today, Surgeons Choose Between Anatomical Access & Invasiveness
Vicarious Surgical Minimally Invasive Surgery Small incisions, but limited anatomical access, visualization and reach, especially in the abdomen. Open Surgery Full anatomical access, but high complications and difficult recovery. Today, Surgeons Choose Between Anatomical Access & Invasiveness Result
Slide 5: Legacy Robot Adoption is Heavily Concentrated in Prostatectomy
Vicarious Surgical Legacy Robot Adoption is Heavily Concentrated in Prostatectomy Not By Design, But By Limitation Current Robotics: Prostatectomy: Built as a General - Purpose System Multi - port entry, rigid arms, and limited freedom of motion. One size fits all approach. The Dominant Robotic Proc
Slide 6: Beyond Prostatectomy: Adoption Drops Sharply
Beyond Prostatectomy: Adoption Drops Sharply Vicarious Surgical
Slide 7: One Small Incision. Unlimited Access.
Vicarious Surgical One Small Incision. Unlimited Access. Open Surgery Access — Through a Single, Small Incision “We are redefining robotic surgery — expanding access to millions 1 of procedures beyond the reach of today’s systems.” Prostate Vicarious Surgical Current Robotic Systems Prostate In pros
Slide 8: Simplify Access, Amplify Performance
Vicarious Surgical Simplify access, Amplify Performance. “Single - Port docking may streamline setup and improves procedural efficiency compared with traditional multi - port docking.” Current Robotic Systems Multi - Port Docking is Cumbersome: ● Pre - op planning required ● External and internal co
Slide 9: Breakthrough in Surgical Access and Maneuverability
Vicarious Surgical Breakthrough in Surgical Access and Maneuverability Open - Like Access & Perspective in Abdominal Procedures Surgeon Empowered Natural motion and full anatomical reach for open - like surgery. Hospital Advantage New revenue streams, improved economics, scalable adoption. Future Re
Slide 10: One Small Incision. Unlimited Access.
Vicarious Surgical One Small Incision. Unlimited Access. Open Surgery Access — Through the Smallest 1 Incision 360 ƒ camera articulation with 120 ƒ field of view provides expanded visualization of the operative field & self cleaning . Decoupled actuators enable additional intra - abdominal joints wi
Slide 11: We Are Launching in Ventral Hernia Repair
Vicarious Surgical We Are Launching in Ventral Hernia Repair Starting Where Others Can’t Go: Redefining Abdominal Access With the ability to work up, down and even backwards, Vicarious Surgical can reach areas of the abdominal wall that are currently difficult or even impossible with other systems .
Slide 12: 5.6 Million abdominal procedures performed annually in the US
Vicarious Surgical 5.6 Million abdominal procedures performed annually in the US 1 We Are Addressing Procedures That Are Not Currently Being Done with Today’s Robotics Vicarious Surgical is expanding the TAM for robotic surgery, not fighting for a slice of the current pie. 82% are still non - roboti
Slide 13: Vicarious Surgical is Positioned for a Different TAM
Vicarious Surgical Vicarious Surgical is Positioned for a Different TAM 82% Non - Robotic (US abdominal procedures market 1 ) 18% Robot - Assisted 1 1: VS ESTIMATES FROM 2021 - 2024 LSI GLOBAL MARKET DATA AND 2019 BANK OF AMERICA GLOBAL MARKET RESEARCH. Includes Hernia, Gallbladder, GI & Gynecologic
Slide 14: Competitive Landscape
Vicarious Surgical Competitive Landscape* Technical Innovation/Novelty Operational Efficiency OR Integration (# Capital Components) Visualization & Display Anatomical Access (DOF) Invasiveness (Incisions) Least invasive, single incision w/ greatest range of motion Easy 1 arm set - up, portable 2 360
Slide 15: Our Proprietary Technology is Secured By A Comprehensive IP
Vicarious Surgical Our Proprietary Technology is Secured By A Comprehensive IP Single Port Insertion Intra - abd. motion 9 DOF Instruments Decoupled Actuators 18 38 37 17 AI & Automation Surgeon Interface 360 ƒ Visualization Camera Cleaning 15 21 39 5 granted/allowed patents 30 87 pending 117 total
Slide 16: Surgeons Validate the Vision of Vicarious Surgical
Vicarious Surgical Surgeons Validate the Vision of Vicarious Surgical The next frontier of robotic surgery is here and I look forward to the continued development of the innovative Vicarious Surgical robotic system.” – Igor Belyansky, MD It's very exciting, very exciting. I like the fact that you ca
Slide 17: Trusted by Leading Visionary Investors
Vicarious Surgical Trusted by Leading Visionary Investors Visionary investors share our belief: Vicarious Surgical will expand robotic surgery into millions of new procedures. Backed by the world’s most forward thinking investors. Leading strategic investors validate Vicarious Surgical’s vision of e
Slide 18: From Engineering to Production
From Engineering to Production Transitioning from controlled builds to regulatory pathway & clinical testing. Vicarious Surgical
Slide 19: Deliberate Progress Toward Clinical Readiness
Vicarious Surgical 1. Beta 2 Established feasibility of core kinematics & vision. • Proof of concept demonstrated • Instrument range of motion validated 2. EV2 Incorporated surgeon feedback from Beta 2. • Reduced instrument size • Improved camera field of view • Redesigned patient cart boom 3 . pDV
Slide 20: Two Controlled Builds: Foundation for Scale
Vicarious Surgical Two Controlled Builds: Foundation for Scale Vicarious Surgical achieved one of the most important milestones in the development of our robotic surgical platform ● April 2025: First controlled build → fully documented, traceable, auditable. ● August 2025: Rebuilt faster and more ef
Slide 21: Progressing Toward Clinical-Grade System
Vicarious Surgical Progressing Toward Clinical - Grade System Apr/25 The first system built to a standard suitable for regulatory testing and clinical use. Aug/25 Sept/25 Mid/26 ● Steady incorporation of remaining design requirements. ● Functionality increased from 49% (June) → 63% (Sept) → clear pa
Slide 22: Demonstrated Improvements: Camera Performance
Vicarious Surgical Demonstrated Improvements: Camera Performance 8/19 Syndaver lab with KOL Dr. Belyansky 9/16 Syndaver lab with KOL Dr. Belyansky Camera focus and fogging issues resolved NOTE: VIDEOS AT 2X SPEED
Slide 23: Next Phase: De-Risked Entry Into Clinical Testing
Vicarious Surgical Next Phase: De - Risked Entry Into Clinical Testing Apr/25 Aug/25 Sept/25 Mid/26 Yr - End/26 ● Year - End 2026: Clinical Readiness milestone → all requirements frozen, hardened system, stable and reliable. ● 2027: ▪ Entering regulatory V&V from a de - risked position (continuous v
Slide 24: Join Us In Transforming Surgery
Vicarious Surgical: Bringing An Open - Surgery Experience to Robotics Join Us In Transforming Surgery For Millions Of Patients Worldwide Vicarious Surgical 78 Fourth Avenue Waltham, MA 02451 US [email protected] Vicarious Surgical
Vicarious Surgical — Investor Presentation (September 2025) on 6ix